Masaya Matsuda

Hirakata, 5730101, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Myofibroblasts Acquire Steroid Resistance via Bcl-xL in Asthmatic Lung Fibrosis.

Myofibroblasts Acquire Steroid Resistance via Bcl-xL in Asthmatic Lung Fibrosis.

Journal: Biological & pharmaceutical bulletin

Published: June 03, 2026

Roles of group 2 innate lymphoid cells in development of steroid-resistant severe asthma and their therapeutic targets.

Roles of group 2 innate lymphoid cells in development of steroid-resistant severe asthma and their therapeutic targets.

Journal: Immunology letters

Published: January 03, 2026

Subcutaneous immunotherapy-induced IgG1 suppresses allergic airway inflammation through FcγRIIb-mediated inhibition of group 2 innate lymphoid cell proliferation.

Subcutaneous immunotherapy-induced IgG1 suppresses allergic airway inflammation through FcγRIIb-mediated inhibition of group 2 innate lymphoid cell proliferation.

Journal: The World Allergy Organization journal

Published: December 02, 2025

Tacrolimus attenuates Th17 cell-mediated allergic skin inflammation in mice.

Tacrolimus attenuates Th17 cell-mediated allergic skin inflammation in mice.

Journal: Journal of pharmacological sciences

Published: October 20, 2025

Roles of extracellular vesicles in allergen-specific immunotherapy

Roles of extracellular vesicles in allergen-specific immunotherapy

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: July 02, 2025

Essential roles of mechanistic target of rapamycin in the induction of steroid resistance in group 2 innate lymphoid cells and severe asthma.

Essential roles of mechanistic target of rapamycin in the induction of steroid resistance in group 2 innate lymphoid cells and severe asthma.

Journal: The Journal of pharmacology and experimental therapeutics

Published: June 24, 2025

Inhibition of cyclin-dependent kinase 4/6 attenuates airway remodeling in a murine severe asthma model by suppressing group 2 innate lymphoid cells proliferation.

Inhibition of cyclin-dependent kinase 4/6 attenuates airway remodeling in a murine severe asthma model by suppressing group 2 innate lymphoid cells proliferation.

Journal: The Journal of pharmacology and experimental therapeutics

Published: April 15, 2025

Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell-related lung fibrosis by activating STAT5.

Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell-related lung fibrosis by activating STAT5.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 05, 2024

Involvement of CCR5 on interstitial macrophages in the development of lung fibrosis in severe asthma.

Involvement of CCR5 on interstitial macrophages in the development of lung fibrosis in severe asthma.

Journal: International immunopharmacology

Published: April 07, 2024

Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma.

Involvement of Janus kinase-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells in asthma.

Journal: Immunology

Published: February 08, 2024

Steroid-Insensitive Gene Expression of Extracellular Matrix Components and Pro-fibrotic Factors in the Lung Associated with Airway Hyperresponsiveness in Murine Asthma.

Steroid-Insensitive Gene Expression of Extracellular Matrix Components and Pro-fibrotic Factors in the Lung Associated with Airway Hyperresponsiveness in Murine Asthma.

Journal: Biological & pharmaceutical bulletin

Published: January 21, 2024

Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells.

Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells.

Journal: Cells

Published: January 17, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026